Effects of radiofrequency electromagnetic fields (RF EMF) on cancer in laboratory animal studies (WHO SR2)
Abstract
Abstract Summary
Background
The carcinogenic potential of radiofrequency electromagnetic fields (RF EMF) was assessed by the International Agency for Research on Cancer (IARC) in 2011, classifying them as possibly carcinogenic to humans (Group 2B). The World Health Organization (WHO), in a 2018 survey of RF experts, prioritized six major topics on potential RF EMF-related human health effects for systematic reviews.
Objective
This study aims to systematically review the effects of RF EMF exposure on cancer outcomes in laboratory animals as part of WHO’s Radiation Program.
Methods
- Follows the WHO's Handbook for guideline development (2014), adapted as necessary.
- Eligible studies are selected based on PECO criteria and include peer-reviewed articles and reports from government agencies.
- Comprehensive searches of databases such as MEDLINE, Web of Science, Scopus, and EMF Portal.
- Application of the PRISMA 2020 guidelines for reporting methods and results.
- Final evaluation uses the OHAT GRADE approach.
Funding and Conflicts of Interest
Partially financed by the WHO, with author salaries supported by their respective employers. Conflicts of interest disclosed include significant affiliations and financial interests of some authors in relation to the telecommunications industry and governmental bodies.